Kinetics of immune tolerization in a clinical trial on epitope-specific therapy in rheumatoid arthritis (RA)

被引：0
|
作者：
Koffeman, Eva
Amox, Diane
Tremoulet, Adriana
Keogh, Elissa
Zeiseniss, Peter
Gosch, Courtney
Friend, Samantha
Zhang, Xiao
Cutter, Gary
Albani, Salvatore
机构：
[1] Univ Calif San Diego, Dept Med & Pediat, Utrecht, Netherlands
[2] Univ Alabama, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA
来源：
CLINICAL IMMUNOLOGY | 2007年 / 123卷
关键词：
D O I：
10.1016/j.clim.2007.03.454
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S96 / S97
页数：2
相关论文
共 50 条
  • [21] BiP peptides induce epitope-specific T-cell reactions in RA
    Sarah Onuora
    Nature Reviews Rheumatology, 2015, 11 (5) : 259 - 259
  • [22] Kinetics of hydroxychloroquine (HCQ) during high dose therapy in rheumatoid arthritis (RA)
    Martin, SW
    Furst, DE
    Klapperich, R
    Shen, DD
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI94 - PI94
  • [23] IMMUNE CYTOTOXICITY IN RHEUMATOID-ARTHRITIS (RA)
    SILVERMAN, SL
    SCHEINBURG, MA
    YONKOSKY, D
    CATHCART, ES
    JOURNAL OF RHEUMATOLOGY, 1976, 3 (01) : 103 - 103
  • [24] Epitope-Specific Immunotherapy of Rheumatoid Arthritis Clinical Responsiveness Occurs With Immune Deviation and Relies on the Expression of a Cluster of Molecules Associated With T Cell Tolerance in a Double-Blind, Placebo-Controlled, Pilot Phase II Trial
    Koffeman, Eva C.
    Genovese, Mark
    Amox, Diane
    Keogh, Elissa
    Santana, Ernesto
    Matteson, Eric L.
    Kavanaugh, Arthur
    Molitor, Jerry A.
    Schiff, Michael H.
    Posever, James O.
    Bathon, Joan M.
    Kivitz, Alan J.
    Samodal, Rodrigo
    Belardi, Francis
    Dennehey, Carolyn
    van den Broek, Theo
    van Wijk, Femke
    Zhang, Xiao
    Zieseniss, Peter
    Le, Tho
    Prakken, Berent A.
    Cutter, Gary C.
    Albani, Salvatore
    ARTHRITIS AND RHEUMATISM, 2009, 60 (11): : 3207 - 3216
  • [25] CONSERVATIVE HAND THERAPY TREATMENTS IN RHEUMATOID ARTHRITIS (RA) - A RANDOMISED CONTROLLED TRIAL
    Chadwick, A. V.
    Simpson, C. S.
    Murray, K.
    Spicer, J.
    Mulherin, D.
    Jones, P. W.
    Mullis, R.
    Dziedzic, K.
    RHEUMATOLOGY, 2004, 43 : 14 - 14
  • [26] Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse
    Burkhardt, H
    Koller, T
    Engström, Å
    Nandakumar, KS
    Turnay, J
    Kraetsch, HG
    Kalden, JR
    Holmdahl, R
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : 2339 - 2348
  • [27] EARLY PHASE CLINICAL-TRIAL OF AURANOFIN (A) IN RHEUMATOID-ARTHRITIS (RA)
    BROWNE, CD
    BIERI, D
    GRAHAM, GG
    HAAVISTO, T
    CHAMPION, GD
    WALZ, DT
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1980, 10 (02): : 269 - 269
  • [28] Pilot clinical trial of intravenous doxycycline versus placebo for rheumatoid arthritis (RA).
    Pillemer, S
    Gulko, P
    Ligier, S
    Yarboro, C
    Gourley, M
    Goldbach-Mansky, R
    Siegel, R
    Hirsch, R
    Pucino, F
    Bethesda, RW
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S81 - S81
  • [29] Combination therapy and the outcome of rheumatoid arthritis (RA)
    Wolfe, F
    Michaud, K
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S140 - S141
  • [30] DIET THERAPY FOR RHEUMATOID-ARTHRITIS (RA)
    PANUSH, RS
    CARTER, R
    KATZ, P
    KOWSARI, B
    LONGLEY, S
    FINNIE, S
    CLINICAL RESEARCH, 1981, 29 (05): : A851 - A851
12345